0000950170-23-064982.txt : 20231120
0000950170-23-064982.hdr.sgml : 20231120
20231120080007
ACCESSION NUMBER: 0000950170-23-064982
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nanavaty Maulik
CENTRAL INDEX KEY: 0001529708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40672
FILM NUMBER: 231420768
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001856725
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
BUSINESS PHONE: (408) 457-3700
MAIL ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
ownership.xml
4
X0508
4
2023-11-16
0001856725
Rani Therapeutics Holdings, Inc.
RANI
0001529708
Nanavaty Maulik
C/O RANI THERAPEUTICS LLC
2051 RINGWOOD AVE.
SAN JOSE
CA
95131
true
false
false
false
false
Class A Common Stock
2023-11-16
4
P
false
500
1.98
A
500
D
Class A Common Stock
11017
I
By Spouse
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97 to $2.00, inclusive.
The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full
information regarding the number of shares purchased at each separate price within the range.
/s/ Maulik Nanavaty
2023-11-20